GWS
FLXN

Glassman Wealth Services’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Glassman Wealth Services’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-21
Closed – – 1501
2019
Q2 		$0 Buy
+21
New +$242 ﹤0.01% 1486

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Glassman Wealth Services's FLXN Position: Q3 2019 in Review

Glassman Wealth Services sold out of Flexion Therapeutics, Inc. (FLXN) in Q3 2019, closing a stake of 21 shares.

Glassman Wealth Services first reported a position in FLXN in Q2 2019 and held it in 1 quarter. The position peaked at $0 in Q2 2019. 126 funds tracked by Wall St. Rank hold FLXN as of Q3 2019.

  • Glassman Wealth Services reported no remaining Flexion Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Glassman Wealth Services sold 21 Flexion Therapeutics, Inc. shares in Q3 2019.
  • Glassman Wealth Services first reported a position in Flexion Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
  • Glassman Wealth Services's Flexion Therapeutics, Inc. position peaked at $0 in Q2 2019.
  • 126 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2019.

Based on Glassman Wealth Services's 13F filing for Q3 2019, filed 1 Nov 2019.